Endoscopic local injection of early gastric carcinoma with 5-fluorouracil
- 1 June 1984
- journal article
- research article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 29 (6) , 498-501
- https://doi.org/10.1007/bf01296268
Abstract
We treated four patients who had early gastric carcinoma with weekly endoscopic local injections of 5-fluorouracil (5FU). In all four patients the lesions disappeared by endoscopic and biopsy examination within 12–18 weeks of treatment. None of the patients experienced side effects which are usually associated with oral or intravenous administration of 5FU. Two patients eventually underwent surgery. In one, a small focus of carcinoma was identified within the resected stomach; no evidence of carcinoma was found in the other. The remaining two patients have not submitted to surgery and are free of carcinoma by endoscopy for over 1 1/2 years. In this uncontrolled study, endoscopic local injection of 5FU appeared to be effective in treating early gastric carcinoma as assessed by endoscopic and histological criteria. Surgery remains the treatment of choice for early gastric carcinoma. However, further studies of endoscopic injection therapy are needed to determine whether this treatment is appropriate for patients with early gastric carcinoma who are not surgical candidates.This publication has 7 references indexed in Scilit:
- Early Gastric CancerGastroenterology, 1981
- EARLY GASTRIC-CANCER1981
- Comparison of intramural 5-fluorouracil and more conventional routes of drug administration on concentrations in gastric regional lymph nodes: A potential for trans-endoscopic adjuvant chemotherapyJournal of Surgical Oncology, 1979
- 5-fluorouracil given once weekly: Comparison of intravenous and oral administrationCancer, 1971
- Cell Proliferation Kinetics in the Gastrointestinal Tract of ManGastroenterology, 1963
- UPTAKE OF TRITIATED THYMIDINE BY HUMAN TUMORS IN VIVO1962